secwatch.observer — SEC 8-K summary
======================================

Issuer:     GT Biopharma, Inc. (GTBP)
CIK:        0000109657
Form:       8-K
Filed at:   2021-12-21T23:59:59+00:00
Accession:  0001654954-21-013424
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

GT Biopharma director Anthony Cataldo resigns from board
--------------------------------------------------------

- Anthony Cataldo resigned as a member of the Board of Directors on December 15, 2021.
- Filing provides no reason for resignation or any details about a successor.
- The resignation reduces the board size; no immediate replacement announced.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/109657/000165495421013424/0001654954-21-013424-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/109657/000165495421013424/gtbp_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-21-013424

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer